Moleculin Biotech, Inc. Increase (Decrease) in Accrued Liabilities
Moleculin Biotech, Inc. (MBRX) reported Increase (Decrease) in Accrued Liabilities of $1.63 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-13
- Moleculin Biotech, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $1.73M.
- Moleculin Biotech, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$99.00K, a 113.41% decline year-over-year.
- Moleculin Biotech, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $218.00K, a 22.42% decline year-over-year.
- Moleculin Biotech, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was -$549.00K, a 535.71% decline year-over-year.
- Moleculin Biotech, Inc. increase (decrease) in accrued liabilities for fiscal 2025 was $17.00K.
- Moleculin Biotech, Inc. increase (decrease) in accrued liabilities for fiscal 2024 was -$1.11M, a 174.31% decline from fiscal 2023.
- Moleculin Biotech, Inc. increase (decrease) in accrued liabilities for fiscal 2023 was $1.49M, a 326.00% increase from fiscal 2022.
- Moleculin Biotech, Inc. increase (decrease) in accrued liabilities for fiscal 2022 was $350.00K, a 5.91% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.63M 10-Q · filed 2026-08-13 | $1.85M derived: sum of 3 quarters · filed 2026-08-13 | $1.30M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$99.00K 10-Q · filed 2026-05-14 | $119.00K derived: sum of 2 quarters · filed 2026-05-14 | -$430.00K derived: sum of 3 quarters · filed 2026-05-14 | -$820.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $218.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$331.00K derived: sum of 2 quarters · filed 2026-03-18 | -$721.00K derived: sum of 3 quarters · filed 2026-08-13 | $17.00K 10-K · filed 2026-03-18 |
| 2025-09-30 | -$549.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$939.00K derived: sum of 2 quarters · filed 2026-08-13 | -$201.00K 10-Q · filed 2025-11-13 | $80.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$390.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $348.00K 10-Q · filed 2026-08-13 | $629.00K derived: sum of 3 quarters · filed 2026-08-13 | $755.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $738.00K 10-Q · filed 2026-05-14 | $1.02M derived: sum of 2 quarters · filed 2026-05-14 | $1.15M derived: sum of 3 quarters · filed 2026-05-14 | $751.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $281.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $407.00K derived: sum of 2 quarters · filed 2026-03-18 | $13.00K derived: sum of 3 quarters · filed 2026-03-18 | -$1.11M 10-K · filed 2026-03-18 |
| 2024-09-30 | $126.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$268.00K derived: sum of 2 quarters · filed 2025-11-13 | -$1.39M 10-Q · filed 2025-11-13 | $1.03M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$394.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$1.51M 10-Q · filed 2025-08-12 | $908.00K derived: sum of 3 quarters · filed 2025-08-12 | $386.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$1.12M 10-Q · filed 2025-05-13 | $1.30M derived: sum of 2 quarters · filed 2025-05-13 | $780.00K derived: sum of 3 quarters · filed 2025-05-13 | $115.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $2.42M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $1.90M derived: sum of 2 quarters · filed 2025-03-21 | $1.24M derived: sum of 3 quarters · filed 2025-03-21 | $1.49M 10-K · filed 2025-03-21 |
| 2023-09-30 | -$522.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$1.19M derived: sum of 2 quarters · filed 2024-11-08 | -$932.00K 10-Q · filed 2024-11-08 | -$1.01M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$665.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$410.00K 10-Q · filed 2024-08-13 | -$485.00K derived: sum of 3 quarters · filed 2024-08-13 | -$379.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $255.00K 10-Q · filed 2024-05-10 | $180.00K derived: sum of 2 quarters · filed 2024-05-10 | $286.00K derived: sum of 3 quarters · filed 2024-05-10 | $330.00K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | -$75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $31.00K derived: sum of 2 quarters · filed 2024-03-22 | $75.00K derived: sum of 3 quarters · filed 2024-03-22 | $350.00K 10-K · filed 2024-03-22 |
| 2022-09-30 | $106.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $150.00K derived: sum of 2 quarters · filed 2023-11-13 | $425.00K 10-Q · filed 2023-11-13 | $436.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $44.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $319.00K 10-Q · filed 2023-08-10 | $330.00K derived: sum of 3 quarters · filed 2023-08-10 | $763.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $275.00K 10-Q · filed 2023-05-10 | $286.00K derived: sum of 2 quarters · filed 2023-05-10 | $719.00K derived: sum of 3 quarters · filed 2023-05-10 | -$91.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $444.00K derived: sum of 2 quarters · filed 2023-03-22 | -$366.00K derived: sum of 3 quarters · filed 2023-03-22 | $372.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | $433.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$377.00K derived: sum of 2 quarters · filed 2022-11-10 | $361.00K 10-Q · filed 2022-11-10 | $55.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$810.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$72.00K 10-Q · filed 2022-08-12 | -$378.00K derived: sum of 3 quarters · filed 2022-08-12 | -$108.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $738.00K 10-Q · filed 2022-05-11 | $432.00K derived: sum of 2 quarters · filed 2022-05-11 | $702.00K derived: sum of 3 quarters · filed 2022-05-11 | $491.00K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | -$306.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$36.00K derived: sum of 2 quarters · filed 2022-03-24 | -$247.00K derived: sum of 3 quarters · filed 2022-03-24 | $259.00K 10-K · filed 2022-03-24 |
| 2020-09-30 | $270.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $59.00K derived: sum of 2 quarters · filed 2021-11-10 | $565.00K 10-Q · filed 2021-11-10 | $866.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$211.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $295.00K 10-Q · filed 2021-08-11 | $596.00K derived: sum of 3 quarters · filed 2021-08-11 | $252.00K derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $506.00K 10-Q · filed 2021-05-12 | $807.00K derived: sum of 2 quarters · filed 2021-05-12 | $463.00K derived: sum of 3 quarters · filed 2021-05-12 | $601.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $301.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | -$43.00K derived: sum of 2 quarters · filed 2021-03-24 | $95.00K derived: sum of 3 quarters · filed 2021-03-24 | -$1.14M 10-K · filed 2021-03-24 |
| 2019-09-30 | -$344.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$206.00K derived: sum of 2 quarters · filed 2020-11-12 | -$1.44M 10-Q · filed 2020-11-12 | -$964.00K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $138.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$1.10M 10-Q · filed 2020-08-12 | -$620.00K derived: sum of 3 quarters · filed 2020-08-12 | -$634.00K derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | -$1.24M 10-Q · filed 2020-05-11 | -$758.00K derived: sum of 2 quarters · filed 2020-05-11 | -$772.00K derived: sum of 3 quarters · filed 2020-05-11 | $301.00K derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $477.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $463.00K derived: sum of 2 quarters · filed 2020-03-19 | $1.54M derived: sum of 3 quarters · filed 2020-03-19 | $1.40M 10-K · filed 2020-03-19 |
| 2018-09-30 | -$14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $1.06M derived: sum of 2 quarters · filed 2019-11-12 | $923.00K 10-Q · filed 2019-11-12 | $1.65M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-16 | $937.00K 10-Q · filed 2019-08-16 | $1.66M derived: sum of 3 quarters · filed 2019-08-16 | $1.58M derived: sum of 4 quarters · filed 2019-08-16 |
| 2018-03-31 | -$136.00K 10-Q · filed 2019-05-13 | $591.00K derived: sum of 2 quarters · filed 2019-05-13 | $511.00K derived: sum of 3 quarters · filed 2019-05-13 | $597.00K derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-12-31 | $727.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $647.00K derived: sum of 2 quarters · filed 2019-02-21 | $733.00K derived: sum of 3 quarters · filed 2019-02-21 | $495.00K 10-K · filed 2019-02-21 |
| 2017-09-30 | -$80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $6.00K derived: sum of 2 quarters · filed 2018-11-13 | -$232.00K 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $86.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | -$152.00K 10-Q · filed 2018-08-10 | ||
| 2017-03-31 | -$238.00K 10-Q · filed 2018-05-14 | |||
| 2016-12-31 | $0.00 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |